US Patent 12116576 Oligonucleotides for modulating SCN9A expression
Patent 12116576 was granted and assigned to Hoffmann-La Roche Limited on October, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12116576 Oligonucleotides for modulating SCN9A expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
